Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Freestyle Lite, True Metrix), And Segment Forecasts, 2019 - 2025

Published: Nov, 2019 | Pages: 145 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global point-of-care glucose testing market size recorded a revenue of USD 6,017.83 million in 2018 and is expected to reach USD 7,308.69 million by 2025 growing at a CAGR of 2.82%, according to a new report by Grand View Research, Inc. An increase in the demand for point-of-care testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed central lab settings, glucose POCT aids in performing effective diagnosis at the patient's bedside. Easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. 

The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism has propelled the point-of-care glucose testing market players to launch innovative glucose meters in the market. Various companies are investing in the development of needle-less blood glucose monitoring devices to offer painless management of diabetes in patients.

For instance, GlucoTrack - a product manufactured by Integrity Applications (Israel) performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. In addition, Eversense is another painless glucose monitoring subcutaneous implant offered by Senseonics. This implant is able to quantify glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real time.

The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals such as silver, gold, and platinum which effectively reduces the electrical noise further improving accuracy.

Further key findings from the study suggest:

• Accu-Chek Inform II accounted for the largest revenue share in 2018 and is anticipated to maintain this trend throughout the forecast period

• Bayer CONTOUR blood glucose monitoring system is set to grow with a CAGR of 5.5% from 2019-2025

• In terms of volume, the i-STAT ranked above all owing to its multipurpose utility in the diagnostics industry

• North America is the leading regional market due to the higher penetration of novel diagnostic techniques

• Asia Pacific has registered the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of diabetes

• A robust network of local manufacturers has significantly contributed to the revenue generated in this region Some of the key market participants are F. Hoffmann-La Roche Ltd., Abbott, LifeScan, Inc., and Nova Biomedical among others

 Table of Contents

Chapter 1 Research Methodology
                   1.1 Market Segmentation & Scope
                   1.2 Market Definition
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 GVR's internal database
                       1.3.3 Secondary sources & third party perspectives
                       1.3.4 Primary research
                   1.4 Information Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Data Visualization
                   1.6 Data Validation & Publishing
Chapter 2 Executive Summary
Chapter 3 Research Methodology
                   3.1 Information procurement
                   3.2 Data Analysis
Chapter 4 Point-of-Care Glucose Testing Market Variables, Trends & Scope
                   4.1 Market Segmentation & Scope
                       4.1.1 Market driver analysis
                           4.1.1.1 Introduction of CLIA waived tests
                           4.1.1.2 Growing prevalence of diabetes
                           4.1.1.3 Rising demand for short turnaround time glucose POC testing
                       4.1.2 Market restraint analysis
                           4.1.2.1 Potential interference and calibration issues in glucose meters
                           4.1.2.2 Presence of ambiguous regulatory as well as reimbursement framework for primary care setting
                   4.2 Point-of-care diagnostics SWOT analysis, by factor (Political & legal, economic, and technological)
                   4.3 Industry Analysis - Porter's
                   4.4 Pipeline Analysis
                       4.4.1 Product pipeline by Phase
                       4.4.2 Pipeline glucose meters; 2017
                       4.4.3 Product pipeline by Applicant
Chapter 5 Point-of-Care Glucose Testing Market Categorization: Product Estimates & Trend Analysis
                   5.1 Global Glucose Point-of-Care Diagnostics/Testing Market: Product Movement Analysis
                   5.2 Accu-Chek
                       5.2.1 Accu Check Aviva meter market revenue, 2014 - 2025 (USD Million)
                       5.2.2 Accu Check Aviva meter market volume, 2014 - 2025 (Thousand Units)
                   5.3 Onetouch Verio Flex
                       5.3.1 Onetouch Verio Flex market revenue, 2014 - 2025 (USD Million)
                       5.3.2 Onetouch Verio Flex market volume, 2014 - 2025 (Thousand Units)
                   5.4 i-STAT
                       5.4.1 i-STAT market revenue, 2014 - 2025 (USD Million)
                       5.4.2 i-STAT market volume, 2014 - 2025 (Thousand Units)
                   5.5 FreeStyle Lite
                       5.5.1 FreeStyle Lite market revenue, 2014 - 2025 (USD Million)
                       5.5.2 FreeStyle Lite market volume, 2014 - 2025 (Thousand Units)
                   5.6 Bayer CONTOUR Blood Glucose Monitoring System
                       5.6.1 Bayer CONTOUR blood glucose monitoring system market revenue, 2014 - 2025 (USD Million)
                       5.6.2 Bayer CONTOUR blood glucose monitoring system market volume, 2014 - 2025 (Thousand Units)
                   5.7 True Metrix
                       5.7.1 True Metrix market revenue, 2014 - 2025 (USD Million)
                       5.7.2 True Metrix market volume, 2014 - 2025 (Thousand Units)
                   5.8 Accu-Chek Inform II
                       5.8.1 Factors favouring the usage of Accu-Chek Inform II
                       5.8.2 Accu-Chek Inform II market revenue, 2014 - 2025 (USD Million)
                       5.8.3 Accu-Chek Inform II market volume, 2014 - 2025 (Thousand Units)
                   5.9 StatStrip
                       5.9.1 Factors favouring the usage of StatStrip
                       5.9.2 StatStrip market revenue, 2014 - 2025 (USD Million)
                       5.9.3 StatStrip market volume, 2014 - 2025 (Thousand Units)
Chapter 6 Point-of-Care Glucose Testing Market Categorization: Regional Estimates & Trend Analysis
                   6.1 North America
                       6.1.1 North America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                       6.1.2 North America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.1.3 U.S.
                           6.1.3.1 U.S. point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.1.3.2 U.S. point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.1.4 Canada
                           6.1.4.1 Canada point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.1.4.2 Canada point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                   6.2 Europe
                       6.2.1 Europe point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                       6.2.2 Europe point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.2.3 Germany
                           6.2.3.1 Germany point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.2.3.2 Germany point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.2.4 UK
                           6.2.4.1 UK point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.2.4.2 UK point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.2.5 France
                           6.2.5.1 France point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.2.5.2 France point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.2.6 Italy
                           6.2.6.1 Italy point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.2.6.2 Italy point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.2.7 Spain
                           6.2.7.1 Spain point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.2.7.2 Spain point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.2.8 Russia
                           6.2.8.1 Russia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.2.8.2 Russia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                   6.3 Asia Pacific
                       6.3.1 Asia Pacific point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                       6.3.2 Asia Pacific point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.3.3 Japan
                           6.3.3.1 Japan point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.3.3.2 Japan point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.3.4 China
                           6.3.4.1 China point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.3.4.2 China point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.3.5 India
                           6.3.5.1 India point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.3.5.2 India point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.3.6 Australia
                           6.3.6.1 Australia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.3.6.2 Australia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.3.7 Korea
                           6.3.7.1 Korea point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.3.7.2 Korea point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.3.8 Singapore
                           6.3.8.1 Singapore point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.3.8.2 Singapore point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                   6.4 Latin America
                       6.4.1 Latin America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                       6.4.2 Latin America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.4.3 Brazil
                           6.4.3.1 Brazil point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.4.3.2 Brazil point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.4.4 Mexico
                           6.4.4.1 Mexico point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.4.4.2 Mexico point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                   6.5 Middle East & Africa.
                       6.5.1 Middle East & Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                       6.5.2 Middle East & Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.5.3 South Africa
                           6.5.3.1 South Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.5.3.2 South Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
                       6.5.4 Saudi Arabia
                           6.5.4.1 Saudi Arabia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
                           6.5.4.2 Saudi Arabia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
Chapter 7 Competitive Landscape
                   7.1 Strategy Framework
                   7.2 Market Participation Categorization
                   7.3 Company Profiles
                       7.3.1 F. Hoffmann-La Roche Ltd.
                           7.3.1.1 Company overview
                           7.3.1.2 Financial performance
                           7.3.1.3 Product benchmarking
                           7.3.1.4 Strategic initiatives
                       7.3.2 Abbott
                           7.3.2.1 Company overview
                           7.3.2.2 Alere
                               7.3.2.2.1 Company overview
                           7.3.2.3 Financial performance
                               7.3.2.3.1 Financial performance
                           7.3.2.4 Product benchmarking
                           7.3.2.5 Strategic initiatives
                       7.3.3 Nipro
                           7.3.3.1 Company overview
                           7.3.3.2 Financial performance
                           7.3.3.3 Product benchmarking
                       7.3.4 Platinum Equity, LLC. (LifeScan, Inc.)
                           7.3.4.1 Company overview
                           7.3.4.2 Product benchmarking/Product portfolio
                           7.3.4.3 Strategic initiatives
                       7.3.5 Nova Biomedical
                           7.3.5.1 Company overview
                           7.3.5.2 Financial performance
                           7.3.5.3 Product benchmarking/Product portfolio
                           7.3.5.4 Strategic initiatives
                       7.3.6 ACON Laboratories, Inc.
                           7.3.6.1 Company overview
                           7.3.6.2 Financial performance
                           7.3.6.3 Product benchmarking/Product portfolio
                           7.3.6.4 Strategic initiatives
                       7.3.7 Trividia Health, Inc.
                           7.3.7.1 Company overview
                           7.3.7.2 Financial performance
                           7.3.7.3 Product benchmarking/Product portfolio
                           7.3.7.4 Strategic initiatives
                       7.3.8 Prodigy Diabetes Care, LLC.
                           7.3.8.1 Company overview
                           7.3.8.2 Product benchmarking/Product portfolio
                       7.3.9 Bayer AG/Ascensia Diabetes Care Holdings AG
                           7.3.9.1 Company overview
                           7.3.9.2 Product benchmarking/Product portfolio
                           7.3.9.3 Financial performance
                       7.3.10 EKF Diagnostics
                           7.3.10.1 Company overview
                           7.3.10.2 Financial performance
                           7.3.10.3 Product benchmarking

List of Tables

TABLE 1 Examples: CLIA waived tests
TABLE 2 North America diabetes prevalence (National prevalence %), 2013 & 2035
TABLE 3 Europe diabetes prevalence (National prevalence %), 2013 & 2035
TABLE 4 Asia Pacific diabetes prevalence (National prevalence %), 2013 & 2035
TABLE 5 Latin America diabetes prevalence (National prevalence %), 2013 & 2035
TABLE 6 MEA and Africa diabetes prevalence (National prevalence %), 2013 & 2035
TABLE 7 CIS diabetes prevalence (National prevalence %), 2013 & 2035
TABLE 8 Specifications of Accu-Chek
TABLE 9 Specifications of Accu-Chek Guide Me meter
TABLE 10 Specifications of Accu-Chek Aviva meter
TABLE 11 Specifications of Accu-Chek Aviva meter
TABLE 12 Specifications of Accu-Chek Nano meter
TABLE 13 Specifications of OneTouch Verio Flex meter
TABLE 14 Specifications of i-STAT analyser
TABLE 15 Specifications of FreeStyle Lite system
TABLE 16 Specifications of Bayer CONTOUR meter
TABLE 17 Specifications of TRUE METRIX
TABLE 18 Features and properties of ACCU-CHEK INFORM II
TABLE 19 Specifications of STATSTRIP
TABLE 20 STATSTRIP: Improved Sensitivity for Detecting Hypoglycemia
TABLE 21 Significant decline in deaths caused by StatStrip
TABLE 22 Glucose meter offered by One Drop
TABLE 23 HemoCue AB: Glucose POC diagnostics
TABLE 24 Dexcom glucose testing products marketed in France
TABLE 25 Some of the local glucose POC testing manufacturers in China
TABLE 26 Some of the local glucose POC testing manufacturers in India
TABLE 27 Primary guidelines for glucose POC testing in Australia
TABLE 28 Prevalence of diabetes and related risk factors; 2016
TABLE 29 Availability of basic technologies in the Brazilian primary care facilities

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Point-of-care diagnostics: Market trends & outlook
FIG. 8 Market segmentation & scope
FIG. 9 Glucose point-of-care diagnostics/testing market: Driver relevance analysis (Current & future impact)
FIG. 10 Shift in POC molecular diagnostic trends
FIG. 11 Current and projected prevalence of diabetes, by geography, 2013 & 2035 (%)
FIG. 12 Schematic representation of POCT device connectivity
FIG. 13 Point of care diagnostics market: Restraint relevance analysis (Current & future impact)
FIG. 14 Point-of-care diagnostics: SWOT analysis, by factor (Political & legal, economic, and technological)
FIG. 15 Point-of-care diagnostics: Porter's five forces analysis
FIG. 16 Glucose point-of-care diagnostics market product outlook key takeaways
FIG. 17 Accu Check Aviva meter market revenue, 2014 - 2025 (USD Million)
FIG. 18 Accu Check Aviva meter market volume, 2014 - 2025 (Thousand Units)
FIG. 19 Onetouch Verio Flex market revenue, 2014 - 2025 (USD Million)
FIG. 20 Onetouch Verio Flex market volume, 2014 - 2025 (Thousand Units)
FIG. 21 i-STAT market revenue, 2014 - 2025 (USD Million)
FIG. 22 i-STAT market volume, 2014 - 2025 (Thousand Units)
FIG. 23 FreeStyle Lite market revenue, 2014 - 2025 (USD Million)
FIG. 24 FreeStyle Lite market volume, 2014 - 2025 (Thousand Units)
FIG. 25 Bayer CONTOUR blood glucose monitoring system market revenue, 2014 - 2025 (USD Million)
FIG. 26 Bayer CONTOUR blood glucose monitoring system market volume, 2014 - 2025 (Thousand Units)
FIG. 27 True Metrix market revenue, 2014 - 2025 (USD Million)
FIG. 28 True Metrix market volume, 2014 - 2025 (Thousand Units)
FIG. 29 Accu-Chek Inform II market revenue, 2014 - 2025 (USD Million)
FIG. 30 Accu-Chek Inform II market volume, 2014 - 2025 (Thousand Units)
FIG. 31 StatStrip market revenue, 2014 - 2025 (USD Million)
FIG. 32 StatStrip market volume, 2014 - 2025 (Thousand Units)
FIG. 33 Regional market place: Key takeaways
FIG. 34 North America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 35 North America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 36 U.S. point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 37 U.S. point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 38 Canada point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 39 Canada point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 40 Europe point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 41 Europe point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 42 Germany point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 43 Germany point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 44 UK point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 45 UK point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 46 France point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 47 France point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 48 Italy point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 49 Italy point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 50 Spain point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 51 Spain point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 52 Russia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 53 Russia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 54 Asia Pacific point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 55 Asia Pacific point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 56 Japan point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 57 Japan point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 58 China point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 59 China point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 60 India point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 61 India point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 62 Australia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 63 Australia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 64 Korea point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 65 Korea point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 66 Singapore point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 67 Singapore point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 68 Latin America point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 69 Latin America point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 70 Brazil point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 71 Brazil point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 72 Mexico point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 73 Mexico point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 74 Middle East & Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 75 Middle East & Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 76 South Africa point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 77 South Africa point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 78 Saudi Arabia point-of-care glucose testing market revenue, 2014 - 2025 (USD Million)
FIG. 79 Saudi Arabia point-of-care glucose testing market volume, 2014 - 2025 (Thousand Units)
FIG. 80 Strategy framework
FIG. 81 Participant categorization